Literature DB >> 33778923

The association of three DNA repair genes polymorphisms on the frequency of chromosomal alterations detected by fluorescence in situ hybridization.

Fábio Santiago1,2,3, Rafaele Tavares Silvestre1,2, Ubirani Barros Otero4, Marianne Medeiros Tabalipa4, Marilza de Moura Ribeiro-Carvalho1,2, Luciano Rios Scherrer5, Ahmed Al-Rikabi3, Thomas Liehr3, Gilda Alves6,7, Maria Helena Ornellas1,2.   

Abstract

PURPOSE: Gas station workers (GSWs) are exposed to carcinogenic agents. The aim was to study the association of high somatic chromosome alterations (CAs) rates in the blood of GSWs and the polymorphisms of three genes playing a role in DNA double-strand break repair.
METHODS: This is a cross-sectional study with 114 GSWs and 115 age-matched controls. Cytogenetic analyses, blood exams, medical interviews and genotypes for RAD51/G135C (rs1801320), ATM/P1054R (rs1800057) and CHEK2/T470C (rs17879961) genes were performed.
RESULTS: The CA rate in GSWs was 9.8 CAs/1000 metaphases, and 19.1% of the workers had > 10 CAs per 1000 metaphases (group two). GSWs had decreased levels of monocytes (P = 0.024) in their blood exams. The number of variant alleles of the RAD51/G135C polymorphism was higher in GSWs (P = 0.011) compared to the controls, and were associated with enhanced number of CAs per worker (P = 0.008). No allele variant was found for CHEK2/T470C in this study.
CONCLUSION: The RAD51/G135C polymorphism appears to be related to genome instability in gas station workers. Increasing the knowledge of DNA repair gene variations involved in maintaining genomic stability in GSWs may be crucial for future cancer prevention.
© 2021. The Author(s).

Entities:  

Keywords:  ATM/P1054R; Benzene; Chromosome aberration; Gas station worker; RAD51/G135C

Mesh:

Substances:

Year:  2021        PMID: 33778923      PMCID: PMC8384795          DOI: 10.1007/s00420-021-01652-8

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


Introduction

BTEX (benzene, toluene, ethyl benzene, and xylene) are aromatic hydrocarbons widely used as solvents in fuels, being chemical contaminants in gas stations´ environments. Benzene is considered the main carcinogenic agent (group one according to IARC), and the association with cancer is well-established (IARC 2018; Falzone et al. 2016). In Brazil, as self-service fuel filling at gas stations is illegal, gas station workers (GSWs) have to fill the fuel in the car’s tank; due to this, they are chronically exposed to high concentrations of BTEX. Although the mechanisms by which BTEX cause genotoxic effects are not fully clear, there is evidence that the function of a wide range of cellular targets are perturbed by specific metabolites and reactive oxygen species (ROS). Genotoxic effects include: (one) inhibition of topoisomerase II; (two) adduct formation of reactive metabolites; (three) oxidative DNA damage; (four) error-prone DNA repair; and (five) epigenetic alterations (McHale et al. 2011; Dewi et al. 2020). Chromosome alterations (CAs) are standardized biomarkers of early biological effects in human biomonitoring. In fact, CAs in peripheral blood lymphocytes reflect inter-individual sensitivity to exogenous genotoxic substances and can be used as biomarker of carcinogenic risk (Rossner et al. 2005; Mateuca et al. 2012; Zhang et al. 2012; Li et al. 2015; Villalba-Campos et al. 2016). Fluorescence in situ hybridization (FISH) using whole chromosome painting (wcp) probes allows a rapid detection of CAs, enabling new possibilities of cytogenetic dosimetry (Verdorfer et al. 2001; Santiago et al. 2014). Lower activity of the DNA repair mechanisms may generate higher somatic rates of CAs, favoring the development of cancer (De Palma and Manno 2014). The DNA repair genes RAD51, ATM, and CHEK play a role in the DNA double-strand break repair preventing CAs; however, some polymorphisms could made this task less efficient. The aims of this study were to assess the frequency of the RAD51/G135C (rs1801320), ATM/P1054R (rs1800057) and CHEK2/T470C (rs17879961) polymorphisms and their putative association with the CAs, along with the evaluation of the health of 114 GSWs in Rio de Janeiro. The polymorphisms RAD51/G135C, ATM/P1054R, and CHEK2/T470C were selected because they were associated with many cancers, such as prostate, breast, head and neck cancer, and leukemias (Skasko et al. 2009; Schumacher et al. 2018; Zeng et al. 2018).

Subjects and methods

Population study

This is a cross-sectional study with 114 workers (60 men and 54 women) recruited at 11 gas stations in Rio de Janeiro and 115 age-matched controls (64 men and 51 women). A trained interviewer questioned the members of the study population regarding their age, sex, skin color (self-declaration), life-style (smoking habits, alcohol and illicit drug consumption, etc.) and about their offspring (Table 1). The control groups were recruited among administrative workers, cleaning workers, and nurses (not exposed to chemotherapy neither X-rays) of two hospitals, in a church (housewives and workers) and teaches. By the questionnaire, we did not detected high exposure to tobacco, alcohol consumption or industrialized food intake. Individuals showing alterations in the blood test were excluded from the control group. The minimum period of exposure for the GSW was 6 months. If the participant had undergone any kind of surgery, either was exposed to X-ray, or was infected by arboviruses in 3 months before the interview, man or woman was excluded from the study. No medication causing CA was reported by the participants. No test for virus was conducted in the blood of the subjects, nevertheless we asked for previous diseases. The subjects reported no hereditary condition although some have reported cases of cancer in the family. It was unclear if the cancer was hereditary. No significant difference was found in smoking cigarettes, alcohol consumption or industrialized food intake between the GSW group and the control´s.
Table 1

Demographics data of gas station workers

DataGroup 1Group 2Group 1 × Group 2(P -value)Total of workersControlsTotal of workers  ×  controls (P value)
Gender0.0350.235
 Women39 (42.4%)15 (68.2%)54 (47.4%)64 (55.7%)
 Men53 (57.6%)7 (31.8%)60 (52.6%)51 (44.3%)
Age (year)38.9 (± 12.4)38.8 (± 12.51)0.90038.84 (± 12.42)36.43 (± 12.93)0.101
Time of employment (year)5.7. (± 6.0)4.3 (± 3.8)0.574
Skin color0.6380.100
 Black25 (27.2%)8 (36.4%)33 (28.9%)20 (18.2%)
 White14 (15.7%)3 (13.6%)17 (14.9%)48 (43.6%)
 Brown (Mulatto)50 (54.3%)10 (45.5%)60 (52.6%)41 (37.3%)
 Light brown (Native Indians)2 (2.2%)0 (0.0%)2 (1.8%)1 (0.9%)
 Yellow (Asiatic)1 (1.1%)1 (4.5%)2 (1.8%)0 (0.0%)
Alcohol consumption
 No18 (15.8%)52 (45.2%)1.000
 Yes75 (65.8%)51 (44.3%)
Stopped drinking15 (13.2%)5 (4.3%)
Never drank6 (5.3%)7 (6.1%)
First trimester of spontaneous abortion7 (77.8%)1 (11.1%)0.015

P value < 0.05 was considered significant

Descriptive measures: a (± b), a = average and b = standard deviation

Demographics data of gas station workers P value < 0.05 was considered significant Descriptive measures: a (± b), a = average and b = standard deviation Peripheral blood samples were collected for complete hemogram, biochemistry and cytogenetic tests. The workers were divided into two groups (group one, ≤ 10 chromosomal abnormalities per 1,000 metaphases; and group two, > 10 chromosomal abnormalities per 1000 metaphases) and compared to clinical characteristics and genotyping results.

Cytogenetic analyses

The cytogenetic analyses were performed for delimiting GSWs at risk as previously described and for allowing associations between the frequency of lymphocyte CAs, genotyping results, and clinical characteristics (Zhang et al. 2012; Verdorfer et al. 2001; Santiago et al. 2014). Blood samples, 2 mL of heparinized whole blood, were collected by venipuncture. Lymphocyte cultures were performed and chromosomes were prepared according to standard procedures after 48 h of cultivation (Liehr and Claussen 2002). FISH was done as previously reported using homemade wcp probes for chromosomes one, two, and four (Verdorfer et al. 2001; Santiago et al. 2014). One-hundred metaphases were analyzed per GSW and 200 metaphases in 11/115 controls.

Genotyping

Genomic DNA from peripheral blood leukocytes was obtained by phenol–chloroform extraction and analyzed by polymerase chain reaction and restriction enzyme digestion (PCR–RFLP) assays for RAD51/G135C (rs1801320), ATM/P1054R (also known as 3161C > G, rs1800057), and CHEK2/T470C (rs17879961) polymorphisms according to previous publications (Skasko et al. 2009; Green and Sambrook 2012; Schumacher et al. 2018). The PCR reactions were carried out in the VeritiVR Thermal Cycler (Applied Biosystems) and were done using 50–200 ng of genomic DNA, 0.4 µM of each primer, 1 × PCR buffer, 250 µM of dNTPs, 1.5 mM of MgCl2, and 1–2.5 units of Taq polymerase in a 50 µL reaction volume. PCR products were digested with MvaI (RAD51/G135C, 60 °C for 1 h), AlwI (ATM/P1054R, 37 °C for 1 h), and PstI (CHEK2/T430C, 37 °C for 5 min) (New England Biolabs), and then separated by electrophoresis in 10% polyacrylamide, and the digested/separated products were further visualized by silver staining. Positive and negative controls were used in all reactions. Note that for RAD51/G135C polymorphism, the wild allele is represented by the letter "G" (Guanine) and the variant allele by "C" (Cytosine). While for ATM/P1054R polymorphism, the wild allele is represented by the letter "C" (Cytosine) and the variant allele by "G" (Guanine).

Statistical analysis

The Hardy–Weinberg (HW) equilibrium was tested using the Chi-Square () statistic for the goodness-of-fit test for each polymorphism, and the differences in the allele and genotype frequencies between groups were analyzed using standard or Fisher’s exact tests. In the distributed variables, a nonparametric Mann–Whitney test or Goodness-of-fit test (multinomial distribution) was used for comparison of the distributed variables between groups using the IBM SPSS (version 2.0). The odds ratio (OR) was also calculated. For all statistical tests, P value < 0.05 was considered significant.

Results

Clinical and demographic data

The GSWs interviewed in this study routinely worked for six days a week, for eight hours or more per day, with 6.9 years of median time of employment. Regarding age, there were no significant differences between the workers (38.84 ± 12.42) and the control groups (36.43 ± 12.93) (P = 0.101). As for skin color (self-declaration), 52.6% (60/115) self-declared as brown (Mulatto), 14.9% (17/115) white, 28.9% (33/115) black, 1.8% (2/115) light brown (as Native Indians), and 1.8% (2/115) yellow (as Asiatic). A low prevalence of smoking (7%) and moderate consumption of alcohol beverage were identified. No statistical differences were found between alcohol consumption, illicit drug use (marijuana, cocaine, and ecstasy), smoking, and race between workers and controls (P = 1.000; P = 1.000; P = 0.293; P = 0.100, respectively; see Table 1). Despite no statistical difference for gender between workers and controls, a higher number of women were observed in group two (68.2%) compared to group one (42.4%) (P = 0.035). Regarding the comparative analyses of blood tests, monocytes, eosinophils, basophils, hemoglobin (men), hematocrit (men), and gamma-gt were found to be significantly higher in the workers group, when compared with the controls (P = 0.001; P < 0.001; P < 0.001, P = 0.001, P = 0.003, and P < 0.001, respectively). On the other hand, platelets, erythrocytes (women), hemoglobin (women), and neutrophil levels (P = 0.001, P = 0.001, P = 0.003 and P = 0.001, respectively) were lower. It should be noted that only monocytes were associated with a high CA rate (P = 0.024, group one vs. group two), as showed in Table 2.
Table 2

Laboratory data of gas station workers

DataGroup 1Group 2Group 1 × Group 2(P value)Total of workersControlsTotal of workers × controls (P value)
Platelets (109/L)254.16 (± 58.83)255.52 (± 70.85)0.969254.43 (± 60.99)278.29 (± 49.70)0.001
Gamma-GT (U/L)37.17 (± 39.40)28.81 (± 12.61)0.81935.74 (± 35.86)27.00 (± 37.30) < 0.001
Direct bilirubin (mg/dL)0.39 (± 0.17)0.34 (± 0.15)0.2230.14 (± 0.05)0.16 (± 0.07)0.046
Leukocytes (/μL)7318.1 (± 2102.3)7226.2 (± 1291.2)0.7957300.22 (± 1966.01)7778.61 (± 1980.38)0.066
Neutrophils (%)55.41 (± 9.80)55.78 (± 8.36)1.0055.49(± 9.51)59.46 (± 10.92)0.001
Eosinophils (%)3.10 (± 2.76)2.73 (± 1.61)0.9513.03 (± 2.58)2.14 (± 3.09) < 0.001
Basophils (%)0.42 (± 0.34)0.33 (± 0.23)0.5770.40 (± 0.32)0.27 (± 0.43) < 0.001
Typical lymphocytes (%)33.62 (± 8.92)35.05 (± 7.89)0.38533.89 (± 8.72)±32.44 (±9.79)0.152
Monocytes (%)7.40 (± 2.04)6.24 (± 1.55)0.0247.18 (± 2.00)5.42 (± 1.95) < 0.001
Reticulocytes (%)±1.13 (±0.38)1.19 (±0.30)0.2091.15 (± 0.36)1.27 (± 0.46)0.080
Women
 Erythrocytes (million/μL)4.48 (± 0.22)4.31 (± 0.35)0.1484.44 (± 0.37)4.62 (± 0.48)0.056
 Hemoglobin13.06 (± 1.1)12.54 (± 1.09)0.11712.92(± 1.11)13.58 (± 1.88)0.021
 Hematocrit (%)38.76 (± 2.98)37.42 (± 3.02)0.21638.40(± 3.02)40.18 (± 3.56)0.002
 Mean corpuscular volume (fl)86.66 (± 5.21)86.86 (± 3.73)0.84586.72 (± 4.82)87.12 (± 5.13)0.511
Men
 Erythrocytes (million/μL)4.98 (± 0.37)4.95 (± 0.11)0.9044.98 (± 0.35)4.72 (± 0.45)0.001
 Hemoglobin14.47 (± 1.13)14.49 (± 0.71)0.88414.47 (± 1.08)13.82 (± 2.08)0.003
 Hematocrit (%)42.37 (± 2.86)42.51 (± 1.55)1.00042.38 (± 2.72)42.23 (± 3.71)0.370
 Mean corpuscular volume (fl)84.90 (± 4.89)84.90 (± 2.42)0.64585.42 (± 4.35)88.07 (± 5.07)0.001

P value < 0.05 was considered significant

Normal values: Platelets 150–400 109/L; gamma-GT 8-71 U/L; direct bilirubin up to 0.3 mg/dL; leukocytes 4000–10,000/μL; neutrophils 40–75%; eosinophils 1–6%; basophils 0–1%; typical lymphocytes 20–45%; monocytes 2–10%, reticulocytes 0.5–2%; erythrocytes 4.5–6.5 million/μL; hemoglobin 13.5–18 g/dL, hematocrit 40–54%, mean corpuscular volume 76–96 fl. Descriptive measures: a (± b), a = average and b = standard deviation

Laboratory data of gas station workers P value < 0.05 was considered significant Normal values: Platelets 150–400 109/L; gamma-GT 8-71 U/L; direct bilirubin up to 0.3 mg/dL; leukocytes 4000–10,000/μL; neutrophils 40–75%; eosinophils 1–6%; basophils 0–1%; typical lymphocytes 20–45%; monocytes 2–10%, reticulocytes 0.5–2%; erythrocytes 4.5–6.5 million/μL; hemoglobin 13.5–18 g/dL, hematocrit 40–54%, mean corpuscular volume 76–96 fl. Descriptive measures: a (± b), a = average and b = standard deviation

The CA data

The GSWs CA rate was 9.8 CAs/1000 metaphases, and a high frequency of CAs (> 10 CAs per 1000 metaphases) was found in 19.1% (22/114) of GSWs, whereas 80.9% (92/114) of workers showed no aberrations or less than ten CAs per 1000 metaphases, and no CAs were found among controls. Chromosome one with 38.4% (43/112) of CAs was the most affected, followed by chromosomes four (32.1%) and two (29.4%); however, no statistical difference was found between the chromosomes and CA distribution (P = 0.494). Among the total CAs, the translocations were most frequently found (38.4%), followed by monosomies (14.3%); deletions (13.4%); chromosomal fragments (13.4%); chromosomal breaks (11.6%); chromosome derivatives (5.3%); trisomies (1.8%), and inversion (1.8%). Figure 1 shows an example of CAs found in one female worker (CAs—del(1),der(2),t(2;?), der(4),t(4;?)).
Fig. 1

CAs found in analyses of one female worker. CAs—del(1),der(2),t(2;?), der(4),t(4;?). The homemade probes were conjugated with TexasRed to label chromosome 1 (red), Diethylaminocoumarin (DEAC) for chromosome 2 (lightblue), and fluorescein isothiocyanate (FITC) for chromosome 4 (green). Other chromosomes were counterstained with DAPI (dark blue)

CAs found in analyses of one female worker. CAs—del(1),der(2),t(2;?), der(4),t(4;?). The homemade probes were conjugated with TexasRed to label chromosome 1 (red), Diethylaminocoumarin (DEAC) for chromosome 2 (lightblue), and fluorescein isothiocyanate (FITC) for chromosome 4 (green). Other chromosomes were counterstained with DAPI (dark blue) The RAD51/G135C, ATM/P1054R, and CHEK2/T470C polymorphisms were determined for GSWs and controls. The RAD51/G135C and ATM/P1054R polymorphisms did not show deviation from the HW equilibrium in the population analyzed (P = 0.322, P = 0.632, respectively), as shown in Table 3. However, the variant genotype (TC and CC) CHEK2/T430C was not found in GSWs or controls; thus, these results were not considered for statistical analysis. Neither RAD51/G135C nor ATM/P1054R polymorphisms were associated with gender or ethnicity. In a comparative population analysis, the frequencies of ATM/P1054R showed no statistical difference between total workers and controls (P = 0.930); however, by the Chi-Square test, the frequencies of RAD51/G135C were different (P = 0.011) (see Table 3), indicating higher frequency of the RAD51/G135C variant in the GSW population.
Table 3

Genotypic frequencies of RAD51/G135C and ATM/P1054R genotypes in 114 gas station workers and 115 controls

RAD51/G135CATM/P1054R
GGGCCCCC GCGG
Group 159 (64.1%)29 (31.5%)4 (4.3%)70 (79.5%)18 (20.5%)0 (0.0%)
Group 29 (40.9%)10 (45.5%)3 (13.6%)19 (86.4%)2 (9.1%)1 (4.5%)
Total of workers N (%)68 (59.6%.)38 (33.3%)8 (7.0%)89 (80.9%)20 (18.2%)1 (0.9%)
Controls N (%)88 (72.2%)24 −(21.1%)2 (1.8%)92 (82.1%)20 (17.9%)0 (0.0%)
Total156 (68.4%)63 (27.6%)9 (3.9%)181 (81.5%)40 (18.0%)1 (0.4%)
P valueP value
Hardy–Weinberg Equilibrium0.3220.632
Total workers × controls0.0110.930
Group 1 × Group 20.0740.092

P value < 0.05 was considered significant

Descriptive measures: a (± b), a = average and b = standard deviation. (a−b), confidence interval sample, 95%

Genotypic frequencies of RAD51/G135C and ATM/P1054R genotypes in 114 gas station workers and 115 controls P value < 0.05 was considered significant Descriptive measures: a (± b), a = average and b = standard deviation. (a−b), confidence interval sample, 95% There was a positive association for a number of CAs per GSW and variants of RAD51/G135C genotypes (P = 0.008, GG + GC × CC; P = 0.011; GG × CC; and P = 0.034, GC × GG), as shown in Table 4. Similar results were found for the distribution of the number of abnormal metaphases per workers (P = 0.005, GG × GC + CC; P = 0.004; GG × CC; and P = 0.028, GG × GC) (see Table 4).
Table 4

Associations between genotypic frequencies of RAD51/G135C in 114 GSW and biometrics (cytogenetic and demographic) data

RAD51/G135CP valueGG × GCP valueGG × CCP valueGC + CC × GG
GG GCCC
Gender N (%)
 Men35 (51.5%)20 (52.6%)6 (75.0%)1.0000.2750.702
Ethnicity N (%)
 Women33 (48.5%)18 (47.4%)2 (25.0%)
 Black18 (26.5%)12 (31.6%)3 (37.5%)0.5550.1640.395
 Mulatto40 (58.8%)18 (47.4%)3 (37.5%)
 White9 (13.2%)6 (15.8%)1 (12.5%)
 Asiatic0 (0.0%)1 (2.6%)1 (12.5%)
 Native Indians1 (1.5%)1 (1.5%)0 (0.0%)
Number of abnormal metaphases per subject0.59 (± 1.4)0.76 (± 1.00)1.63 (± 1.6)0.0280.0040.005
Number of chromosomal aberrations per subject1.63 (± 1.92)0.84 (± 1.94)1.03 (± 1.33)0.0340.0110.008

P value < 0.05 was considered significant

Descriptive measures: a (± b), a = average and b = standard deviation

Associations between genotypic frequencies of RAD51/G135C in 114 GSW and biometrics (cytogenetic and demographic) data P value < 0.05 was considered significant Descriptive measures: a (± b), a = average and b = standard deviation Regarding the comparative analyses for types of chromosomal alterations and RAD51/G135C genotypes, we found a higher number of chromosome fragments (P = 0.004, GG × GC; P = 0.014; GG × GC + CC) and chromosome breaks (P = 0.013, GG × GC) between variant allele genotype groups (Table 5).
Table 5

Associations between genotypic frequencies of RAD51/G135C and types of chromosome alterations

RAD51/G135C P valueGG × GCP value GG × CC P valueGG × CC + GC
GGGCCC
Translocations
 058 (85.3%)26 (68.4%)6 (75.0%)0.1330.7690.126
 16 (8.8%)7 (18.4%)1 (12.5%)
 23 (4.4%)4 (10.5%)1 (12.5%)
 40 (0.0%)1 (2.6%)0 (0.0%)
 51 (1.5%)0 (0%)0 (0.0%)
Chr. fragments
 064 (94.0%)30 (78.9%)8 (100.0%)0.0041.0000.014
 12 (2.9%)8 (21.1%)0 (0.0%)
 21 (1.5%)0 (0%)0 (0.0%)
 31 (1.5%)0 (0%)0 (0.0%)
Chr. Breaks
 063 (94.0%)35 (92.1%)6 (75.0%)0.7870.0130.245
 13 (4.5%)3 (7.9%)0 (0.0%)
 20 (0.0%)0 (0.0%)2 (25.0%)
 31 (1.5%)0 (0.0%)0 (0.0%)
Deletions
 062 (91.2%)34 (91.9%)6 (75.0%)0.7310.1970.774
 14 (5.9%)3 (8.1%)1 (12.5%)
 22 (2.9%)0 (0.0%)1 (12.5%)
Chr. Derivatives
 065 (95.6%)37 (97.4%)8 (100.0%)0.7851.0000.764
 11 (1.5%)1 (2.6%)0 (0.0%)
 22 (2.9%)0 (0.0%)0 (0.0%)
Inversions
 068 (100.0%)36 (97.3%)8 (100.0%)0.3521.0000.398
 10 (0.0%)1 (2.7%)0 (0.0%)
Monosomies
 062 (91.2%)36 (94.7%)6 (75.0%)1.0000.2481.000
 14 (5.9%)2 (5.3%)1 (12.5%)
 21 (1.5%)0 (0.0%)1 (12.5%)
 51 (1.5%)0 (0.0%)0 (0.0%)
Trisomies
 067 (98.5%)37 (97.4%)8 (100.0%)1.0001.0001.000
 11 (1.5%)1 (2.6%)0 (0.0%)

P value < 0.05 was considered significant

Descriptive measures: a (± b), a = average and b = standard deviation

Associations between genotypic frequencies of RAD51/G135C and types of chromosome alterations P value < 0.05 was considered significant Descriptive measures: a (± b), a = average and b = standard deviation The frequencies of ATM/P1054R genotypes were compared between the workers and controls, and no significant difference was detected, indicating that the two populations were equivalent (Table 6). Only a weak positive association with chromosome breaks was detected, when compared between the genotypes with the variants CC × GG + CG (P = 0.054), as shown in Table 7. To assess the capacity of variant alleles RAD51/G135C and ATM/P1054R to detect the workers with CAs, the sensitivity and specificity were calculated. Note a considerable specificity for RAD51/G135C (87%) and ATM/P1054R (79%); however, lower sensitivity was found for both 28% and 14%, respectively. When the specificity was calculated for RAD51/G135C and ATM/P1054R together, the value found was 82% (see Table 3).
Table 6

Statistical analysis of ATM/P1054R genotypes

ATM/P1054RP valueCC × GG + CGP valueCC × CG
CCCGGG
Gender N (%)
 Men42 (47.2%)14 (66.7%)1 (100.0%)0.0970.146
 Women47 (52.8%)7 (33.3%)0 (0.0%)
Ethnicity N (%)
 Black25 (27.8%)7 (33.3%)0 (0.0%)1.0000.976
 Brown47 (52.2%)11 (52.4%)1 (100.0%)
 White14 (15.6%)3 (14.3%)0 (0.0%)
 Asian2 (2.2%)0 (0.0%)0 (0.0%)
 Native American2 (2.2%)0 (0.0%)0 (0.0%)
Number of abnormal metaphases per subject0.74 (± 1.36)0.62 (± 1.12)1 (N)0.9240.913
Number of chromosomal aberrations per subject1.01 (± 1.85)0.71 (± 1.35)2 (N)0.5170.965

Descriptive measures: a (± b), a = average and b = standard deviation

Table 7

Statistical analysis of ATM/P1054R genotypes and chromosome alterations

ATM/P1054RP valueCC × CGP valueCC × GG + CG
CCCGGG
Translocations
 071 (78.9%)16 (76.2%)0 (0.0%)0.7710.781
 110 (11.1%)4 (19.0%)0 (0.0%)
 27 (7.8%)1 (4.8%)0 (0.0%)
 41 (1.1%)0 (0.0%)0 (0.0%)
 51 (1.1%)0 (0.0%)0 (0.0%)
Chr. Fragments
 078 (87.6%)20 (95.2%)0 (0.0%)0.7930.662
 19 (10.1%)1 (4.8%)0 (0.0%)
 21 (1.1%)0 (0%)0 (0.0%)
 31 (1.1%)0 (0%)0 (0.0%)
Chr. breaks
 084 (93.3%)19 (90.5%)0 (0.0%)0.3520.054
 15 (5.6%)1 (4.8%)0 (0.0%)
 20 (0.0%)1 (4.8%)2 (100.0%)
 31 (1.1%)0 (0.0%)0 (0.0%)
Deletions
 079 (87.8%)20 (95.2%)0 (0.0%)0.2750.279
 19 (10.0%)0 (0.0%)0 (0.0%)
 22 (2.2%)1 (4.8%)0 (0.0%)
Chr. derivatives
 087 (96.7%)20 (95.2%)0 (0.0%)0.5730.589
 11 (1.1%)1 (4.8%)0 (0.0%)
 22 (2.2%)0 (0.0%)0 (0.0%)
Inversions
 089 (98.9%)21 (100.0%)0 (0.0%)1.0001.000
 11 (1.1%)0 (2.7%)0 (0.0%)
Monosomies
 082 (91.1%)19 (90.5%)0 (0.0%)0.7990.808
 15 (5.6%)2 (9.5%)0 (0.0%)
 22 (2.2%)0 (0.0%)0 (0.0%)
 51 (1.1%)0 (0.0%)0 (0.0%)
Trisomies
 088 (97.8%)21 (100.0%)0 (0.0%)1.0001.000
 12 (2.2%)0 (0.0%)0 (0.0%)

Descriptive measures: a (± b), a = average and b = standard deviation

Statistical analysis of ATM/P1054R genotypes Descriptive measures: a (± b), a = average and b = standard deviation Statistical analysis of ATM/P1054R genotypes and chromosome alterations Descriptive measures: a (± b), a = average and b = standard deviation

Discussion

The association between two dysfunctional polymorphisms RAD51/G135C and ATM/P1054R, and CAs, as an early effect biomarker, was evaluated in this cross-sectional study. Numerous studies have associated exposure to BTEX with increased levels of CAs in circulating lymphocytes of exposed workers (Zhang et al. 2002, 2012; Santiago et al. 2014; Gonçalves et al. 2016). Increased levels of CAs have, in turn, been correlated with an increased risk of cancer, especially for hematologic malignancies, such as myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML)—(Smith 2010). FISH using wcp probes was applied in our study to detect alterations caused by chronic exposure to BTEX in 21.87% (chromosomes 1, 2, and 4, together) of the human genome (Verdorfer et al. 2001). Similar results were previously described by our research group (Santiago et al. 2014) applying the same technique in GSW populations (rate: 9.3 CAs per 1000 metaphases), as well as results described by Verdorfer et al (2001) in populations exposed to nitroaromates (16.0 CAs per 1000 metaphases) and compared to controls (5.85 CAs per 1000 metaphases). No CA was detected in the control group, fact that draws attention when compared to the high CAs frequency found in GSW group. It is possible GSWs with higher rates of CAs have a higher risk of developing cancer in future than others with low rates of CAs. In the present study, the frequencies of RAD51/G135C variant were higher in the GSW population when compared to controls, and the allele variant genotypes were associated with CAs per workers. In a meta-analysis study on the relationship between RAD51/G135C and cancer risk, Zhao and cowokers (2014) investigated 42 studies involving 19,142 cases and 20,363 controls (Zhao et al. 2014). They found a significantly increased risk for overall cancers and concluded that RAD51/G135C polymorphism is a candidate for susceptibility to cancer in general, especially for breast cancer. In another meta-analysis involving ten studies with, 656 patients and 3725 controls, the RAD51/G135C polymorphism was associated with increased MDS risk, while no association was observed for acute leukemia (He et al. 2014). In our study, chromosome fragments and chromosome breaks were positively associated with variant allele genotypes. There is evidence that in Rad51 deficient cells stop in the G2/M phase and accumulate chromosomal breaks prior to cell death or unregulated cell growth, justifying the association found (Sonoda et al. 1998; Mishra et al. 2018). Regarding the ATM results, no differences were found in the proportion of carriers of the ATM/P1054R variant between workers and controls. However, this proportion was considerably higher among our workers (19.0%, 21 out of 110) compared to prostate cancer patients (9.5%, 25 out of 261) and controls (4.78%, 22 out of 460) described by Meyer and coworkers (2007). A weak positive association between chromosome breaks and the variant ATM/P1054R was detected in our workers, suggesting that more studies are necessary for a final conclusion. In the case of the CHEK2/T470C, no variant alleles were found in our study, possibly due to the low frequency in our study population. CHEK2/T470C is associated with reduced DNA repair ability and increased cancer susceptibility, such as breast cancer, colorectal cancer and prostate cancer (Han et al. 2013; Kilpivaara et al. 2006; Dong et al. 2003). In the USA, the CHEK2/T470C variant has been reported in 1.2% of the population, while in Germany, the frequency was 2.2% in breast cancer cases and 0.6% in controls; and in Belarussian population, 5.7% in cases and 1.3% in controls (Bogdanova et al. 2005). It may be necessary to increase the number of workers to be analyzed to draw conclusions about the CHEK2/T470C polymorphism in the Brazilian GSWs. The literature has also reported an influence of gene–gene interactions on cancer susceptibility. Several studies have shown that combinations of RAD51 and ATM variants may increase the risk for cancer development (Hallajian et al. 2017). In our study, no increase in specificity or sensitivity was found for the RAD51/G135C and ATM/P1054R polymorphism combinations for detecting CAs. Perhaps for an effective GSWs genomic instability monitoring and an increase in the sensitivity and specificity in detecting CAs, it will be necessary to evaluate not only more polymorphisms related to the DNA repair, but also polymorphisms related to BTEX detoxification (Kanuoriya et al. 2015; Fang et al. 2017).

Risk behavior and prevention of cancer

Hematological changes in classic blood tests were previously described (IARC 2018; Zhang et al. 2012; Silvestre et al. 2017). In the present study, a high rate of monocytes, eosinophils, basophils, and gamma-gt was found compared to controls, as previously described (Zhang et al. 2012; Mitri et al. 2015; Otero and Ornellas 2015). However, a lower rate of platelets and neutrophils was associated with the workers. Despite the higher rate of monocytes found in total of workers, a lower rate of monocytes was associated with a high number of CAs (group two), highlighting the importance of the simple classic blood test in monitoring their overall health. Recently, Getu et al (2020) studied GSW in Ethiopia. In disagreement to our study, they found that hematimetric values had a significant increment when compared with the control group. However, they considered that a larger sample size should be conducted to explore the impact of these chemicals on their population. So it will be useful to conduct a meta-analysis study to check points of agreement and disagreement in different world population. We should also consider the high frequency of spontaneous abortions in the first trimester of pregnancy of total abortions reported by the female workers compared to female controls. This was also previously described by Silvestre and coworkers (2017) in a study with a lower number of female GSWs (Silvestre et al. 2017). Thus, the immediate absence of female workers to the gas station once pregnancy is confirmed is necessary to reduce the BTEX`s genotoxic and abortive effects. More maternal–child health studies are needed, since the female gender was associated with a higher number of CAs (group two). Women have shown faster benzene biotransformation than men, metabolizing 23–26% more benzene, and its known that benzene must be bio-transformed to exert its toxic effects. Thus, women may be at greater risk, and environmental/biological limit values established in studies of male subjects may be inadequate (Brown et al. 1998; Angelini et al. 2012; Moro et al. 2017; Santiago et al. 2017).

Conclusion

Herein we describe a health survey and the consequent genome risks related to the chronic exposure to gasoline vapors as well as the possible ways to monitor such risks. CAs are standardized biomarkers used to identify not only the worker population at a higher risk of developing cancer, but also specific individuals who are susceptible to cancer development. The higher frequencies of the RAD51/G135C polymorphism in the GSW population and its association with higher CA frequency are a relevant result. Increasing the knowledge of the DNA repair variations in maintaining the genomic stability and integrity in the GSWs is crucial for cancer prevention. As a result, a better understanding of inter-individual variations in susceptibility, with the identification of groups at higher risk, may provide a foundation for developing better prevention programs.
  35 in total

1.  CHEK2 I157T associates with familial and sporadic colorectal cancer.

Authors:  O Kilpivaara; P Alhopuro; P Vahteristo; L A Aaltonen; H Nevanlinna
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

2.  RAD51C/XRCC3 Facilitates Mitochondrial DNA Replication and Maintains Integrity of the Mitochondrial Genome.

Authors:  Anup Mishra; Sneha Saxena; Anjali Kaushal; Ganesh Nagaraju
Journal:  Mol Cell Biol       Date:  2018-01-16       Impact factor: 4.272

3.  Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death.

Authors:  E Sonoda; M S Sasaki; J M Buerstedde; O Bezzubova; A Shinohara; H Ogawa; M Takata; Y Yamaguchi-Iwai; S Takeda
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

4.  Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.

Authors:  Zeinab Hallajian; Frouzandeh Mahjoubi; Nahid Nafissi
Journal:  Breast Cancer       Date:  2017-01-05       Impact factor: 4.239

5.  Chromosome painting for cytogenetic monitoring of occupationally exposed and non-exposed groups of human individuals.

Authors:  I Verdorfer; S Neubauer; S Letzel; J Angerer; R Arutyunyan; P Martus; M Wucherer; E Gebhart
Journal:  Mutat Res       Date:  2001-04-05       Impact factor: 2.433

6.  Mutations in CHEK2 associated with prostate cancer risk.

Authors:  Xiangyang Dong; Liang Wang; Ken Taniguchi; Xianshu Wang; Julie M Cunningham; Shannon K McDonnell; Chiping Qian; Angela F Marks; Susan L Slager; Brett J Peterson; David I Smith; John C Cheville; Michael L Blute; Steve J Jacobsen; Daniel J Schaid; Donald J Tindall; Stephen N Thibodeau; Wanguo Liu
Journal:  Am J Hum Genet       Date:  2003-01-17       Impact factor: 11.025

7.  The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.

Authors:  Fei-fei Han; Chang-long Guo; Li-hong Liu
Journal:  DNA Cell Biol       Date:  2013-05-13       Impact factor: 3.311

8.  Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer.

Authors:  Elzbieta Skasko; Anna Kluska; Anna Niwińska; Ewa Kwiatkowska; Aneta Bałabas; Magdalena Piatkowska; Michalina Dabrowska; Dorota Nowakowska; Tadeusz Pieńkowski
Journal:  Onkologie       Date:  2009-03-13

9.  Leukemia-related chromosomal loss detected in hematopoietic progenitor cells of benzene-exposed workers.

Authors:  L Zhang; Q Lan; Z Ji; G Li; M Shen; R Vermeulen; W Guo; A E Hubbard; C M McHale; S M Rappaport; R B Hayes; M S Linet; S Yin; M T Smith; N Rothman
Journal:  Leukemia       Date:  2012-05-30       Impact factor: 11.528

Review 10.  Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.

Authors:  Xianling Zeng; Yafei Zhang; Lei Yang; Huiqiu Xu; Taohong Zhang; Ruifang An; Kexiu Zhu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.